IC

Ikarian Capital Portfolio holdings

AUM $302M
1-Year Est. Return 65.21%
This Quarter Est. Return
1 Year Est. Return
+65.21%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$241M
AUM Growth
-$68K
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
106
New
Increased
Reduced
Closed

Top Buys

1
+$10.6M
2
+$9.86M
3
+$8.27M
4
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$7.32M
5
APLS icon
Apellis Pharmaceuticals
APLS
+$6.6M

Top Sells

1
+$17.5M
2
+$10.2M
3
+$5.94M
4
CLDX icon
Celldex Therapeutics
CLDX
+$5.81M
5
ETNB icon
89bio
ETNB
+$5.78M

Sector Composition

1 Healthcare 97.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$13.5M 3.07%
125,926
-163,000
2
$12M 2.73%
774,398
-192,302
3
$11.6M 2.62%
869,390
+194,214
4
$10.6M 2.41%
+100,000
5
$9.86M 2.24%
+594,686
6
$8.54M 1.94%
721,341
-15,978
7
$8.43M 1.91%
225,000
-25,000
8
$8.27M 1.88%
+485,000
9
$7.32M 1.66%
+80,564
10
$6.6M 1.5%
+100,000
11
$6.56M 1.49%
283,464
12
$6.54M 1.48%
+210,975
13
$6.37M 1.45%
885,334
14
$5.74M 1.3%
160,486
15
$5.5M 1.25%
402,326
-435,174
16
$5.23M 1.19%
138,277
17
$5.19M 1.18%
213,521
-163,500
18
$4.86M 1.1%
+50,000
19
$4.59M 1.04%
228,677
-26,454
20
$4.41M 1%
+207,112
21
$4.24M 0.96%
+575,000
22
$4.2M 0.95%
230,000
+92,013
23
$3.94M 0.89%
5,576
+1,921
24
$3.84M 0.87%
208,650
+52,650
25
$3.82M 0.87%
106,057
-161,419
1
2 3 4 5